| Financial Year |
March 31 2023 |
| Monetary Funds |
354,568,720.00 |
| Held-for-trading Financial Assets |
39,124,870.90 |
| Notes Receivable |
-- |
| Accounts Receivable |
326,898,356.19 |
| Advances to Suppliers |
12,179,162.56 |
| Other Receivables |
48,236,246.83 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
1,920,543.49 |
| Dividend Receivable |
-- |
| Inventories |
144,782,225.77 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
10,207,164.38 |
| Other Current Assets |
5,428,318.78 |
| Total Current Assets |
976,758,415.40 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
20,700,953.83 |
| Investment Properties |
119,808,902.52 |
| Fixed Assetes |
129,755,467.05 |
| Under-construction Projects |
2,153,308.27 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
74,948,119.76 |
| R&D expenses |
3,498,028.44 |
| Goodwill |
32,952,039.87 |
| Long-Term Deferred and Prepaid Expenses |
167,750.00 |
| Deferred Income Tax Assets |
21,865,707.03 |
| Other Non-Current Assets |
73,788,016.18 |
| Sub-Total of Non-Current Assets |
579,393,954.76 |
| Total Assets |
1,556,152,370.16 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
7,108,901.00 |
| Accounts Payable |
33,246,572.73 |
| Accounts Received In Advance |
228,438.77 |
| Employee Compensation Payable |
7,053,446.64 |
| Taxes Payable |
5,793,505.05 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
5,445,652.71 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
549,585.86 |
| Other Current Liabilities |
514,640.28 |
| Sub-Total of Current Liabilities |
90,322,464.20 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
433,271.97 |
| Deferred Income Tax Liabilities |
82,179.97 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,553,152.67 |
| Total Liabilities |
92,875,616.87 |
| Paid-In Capital(Or Share Stock) |
676,517,079.00 |
| Capital Surplus |
165,981,179.04 |
| Surplus Reserve |
61,906,297.96 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
527,026,820.49 |
| Minority Stockholder's Interest |
31,845,376.80 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,431,431,376.49 |
| Owner's Equity（Stockholder's Equity） |
1,463,276,753.29 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,556,152,370.16 |
